United Therapeutics Corporation
UTHR
$515.46
-$12.45-2.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 21.13% | -24.54% | 7.56% | 9.43% | -3.94% |
| Total Depreciation and Amortization | 7.08% | -0.88% | 4.11% | 3.79% | 6.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -47.52% | 48.79% | 164.36% | -39.16% | 55.58% |
| Change in Net Operating Assets | -1,100.81% | 108.61% | -188.62% | 180.05% | -360.26% |
| Cash from Operations | -32.31% | 33.82% | -38.41% | 193.22% | -58.43% |
| Capital Expenditure | -7.14% | 41.70% | 17.86% | -238.42% | 16.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -76.85% | 1,643.88% | -115.57% | 247.83% | -164.70% |
| Cash from Investing | -88.23% | 426.76% | -261.53% | 146.98% | -82.09% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -300.00% |
| Issuance of Common Stock | 70.91% | -25.35% | 122.47% | 145.86% | -15.81% |
| Repurchase of Common Stock | 99.97% | -259,616.67% | 99.94% | -19,140.38% | 66.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 108.25% | -1,608.54% | 110.29% | -381.37% | -111.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 288.72% | -227.83% | 185.77% | 17.54% | -251.36% |